Skip to main content
SpringerLink
Log in

Antineoplastics

Pancytopenia and off-label use: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Wilson AJ, et al. Successful remission induction therapy with gilteritinib in a patient with de novo FLT3-mutated acute myeloid leukaemia and severe COVID-19. British Journal of Haematology 190: e189-e191, No. 4, Aug 2020. Available from: URL: http://doi.org/10.1111/bjh.16962

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics. Reactions Weekly 1825, 39 (2020). https://doi.org/10.1007/s40278-020-84279-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-84279-y

Search

Navigation